Patients’ Choice on Axillary Lymph Node Dissection Following Sentinel Lymph Node Micrometastasis — First Report on Prospective Use of a Nomogram in Very Low Risk Patients
The optimal locoregional treatment of patients diagnosed with sentinel node (SN) micrometastasis is controversial. A previously reported and validated nomogram was used to calculate the risk of non-SN metastasis in patients with SN micrometastasis over a period of 2 years. Patients were given detail...
Gespeichert in:
| Veröffentlicht in: | Pathology oncology research 2013-04, Vol.19 (2), p.211-216 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 216 |
|---|---|
| container_issue | 2 |
| container_start_page | 211 |
| container_title | Pathology oncology research |
| container_volume | 19 |
| creator | Cserni, Gábor Bezsenyi, Istvánné Markó, László |
| description | The optimal locoregional treatment of patients diagnosed with sentinel node (SN) micrometastasis is controversial. A previously reported and validated nomogram was used to calculate the risk of non-SN metastasis in patients with SN micrometastasis over a period of 2 years. Patients were given detailed information about the risk, consequences and treatment options of non-SN involvement, the risk and potential complications of unnecessary completion axillary lymph node dissection (ALND), the imperfectness of the nomogram, and other factors that may influence their selection of further treatment. They also received a questionnaire to monitor factors influencing their decisions. Of the 25 patients participating in the study, 10 have opted for ALND. The only factor that seemed to influence their choice was fear from disease recurrence. Giving detailed information to SN micrometastatic patients is a patient-centered alternative to current recommendations on performing ALND in all such patients or omitting ALND in all of them. |
| doi_str_mv | 10.1007/s12253-012-9571-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1326725561</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2943012421</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-d66f8bd3940ca91311b14d8041d0e0b0ceafa81253420803cba1c31d41c592193</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS0EoqXwAGyQJTZsAr52nJ9lNTCANC1VoWwjx3GmLkkcfDOU7voQbHgJHqpP0ptOiyokJEu25O_cc3UOY89BvAYh8jcIUmqVCJBJqXNI1AO2C1rJRBYif0hvCWWSljrbYU8QzwRpsjJ7zHakErnQhd5lf47M5N0w4dXlb744Dd46Hga-_9N3nYkXfHXRj6f8MDSOv_WIzk6evpeh68K5H9b8M2n94Lr74IG3MfRuMkjHI7-6_MWXPuLEj90Y4jQbHMWA4zzth-MnSJ4tN6TuwzqanvuBf3Wzezjnxx6_8bstn7JHrenQPbu999jJ8t2XxYdk9en9x8X-KrEql1PSZFlb1I0qU2FNCQqghrQpRAqNcKIW1pnWFEDhpVIUQtnagFXQpGB1SaGpPfZqO3eM4fvG4VT1Hq2jTAYXNliBklkutc6A0Jf_oGdhEwfa7oZSKstyTRRsKYoGMbq2GqPvKeEKRDWXWW3LrKjMai6zUqR5cTt5U_eu-au4a48AuQWQvoa1i_es_zv1GlSwrKk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1326336675</pqid></control><display><type>article</type><title>Patients’ Choice on Axillary Lymph Node Dissection Following Sentinel Lymph Node Micrometastasis — First Report on Prospective Use of a Nomogram in Very Low Risk Patients</title><source>MEDLINE</source><source>Springer journals</source><creator>Cserni, Gábor ; Bezsenyi, Istvánné ; Markó, László</creator><creatorcontrib>Cserni, Gábor ; Bezsenyi, Istvánné ; Markó, László</creatorcontrib><description>The optimal locoregional treatment of patients diagnosed with sentinel node (SN) micrometastasis is controversial. A previously reported and validated nomogram was used to calculate the risk of non-SN metastasis in patients with SN micrometastasis over a period of 2 years. Patients were given detailed information about the risk, consequences and treatment options of non-SN involvement, the risk and potential complications of unnecessary completion axillary lymph node dissection (ALND), the imperfectness of the nomogram, and other factors that may influence their selection of further treatment. They also received a questionnaire to monitor factors influencing their decisions. Of the 25 patients participating in the study, 10 have opted for ALND. The only factor that seemed to influence their choice was fear from disease recurrence. Giving detailed information to SN micrometastatic patients is a patient-centered alternative to current recommendations on performing ALND in all such patients or omitting ALND in all of them.</description><identifier>ISSN: 1219-4956</identifier><identifier>EISSN: 1532-2807</identifier><identifier>DOI: 10.1007/s12253-012-9571-3</identifier><identifier>PMID: 23070585</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Adult ; Aged ; Axilla ; Biomedical and Life Sciences ; Biomedicine ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Cancer Research ; Choice Behavior ; Female ; Humans ; Immunology ; Lymph Node Excision - methods ; Lymph Nodes - pathology ; Lymph Nodes - surgery ; Lymphatic Metastasis - pathology ; Middle Aged ; Neoplasm Micrometastasis ; Nomograms ; Oncology ; Pathology ; Prospective Studies ; Sentinel Lymph Node Biopsy - methods</subject><ispartof>Pathology oncology research, 2013-04, Vol.19 (2), p.211-216</ispartof><rights>Arányi Lajos Foundation 2012</rights><rights>Arányi Lajos Foundation 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-d66f8bd3940ca91311b14d8041d0e0b0ceafa81253420803cba1c31d41c592193</citedby><cites>FETCH-LOGICAL-c372t-d66f8bd3940ca91311b14d8041d0e0b0ceafa81253420803cba1c31d41c592193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12253-012-9571-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12253-012-9571-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23070585$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cserni, Gábor</creatorcontrib><creatorcontrib>Bezsenyi, Istvánné</creatorcontrib><creatorcontrib>Markó, László</creatorcontrib><title>Patients’ Choice on Axillary Lymph Node Dissection Following Sentinel Lymph Node Micrometastasis — First Report on Prospective Use of a Nomogram in Very Low Risk Patients</title><title>Pathology oncology research</title><addtitle>Pathol. Oncol. Res</addtitle><addtitle>Pathol Oncol Res</addtitle><description>The optimal locoregional treatment of patients diagnosed with sentinel node (SN) micrometastasis is controversial. A previously reported and validated nomogram was used to calculate the risk of non-SN metastasis in patients with SN micrometastasis over a period of 2 years. Patients were given detailed information about the risk, consequences and treatment options of non-SN involvement, the risk and potential complications of unnecessary completion axillary lymph node dissection (ALND), the imperfectness of the nomogram, and other factors that may influence their selection of further treatment. They also received a questionnaire to monitor factors influencing their decisions. Of the 25 patients participating in the study, 10 have opted for ALND. The only factor that seemed to influence their choice was fear from disease recurrence. Giving detailed information to SN micrometastatic patients is a patient-centered alternative to current recommendations on performing ALND in all such patients or omitting ALND in all of them.</description><subject>Adult</subject><subject>Aged</subject><subject>Axilla</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Cancer Research</subject><subject>Choice Behavior</subject><subject>Female</subject><subject>Humans</subject><subject>Immunology</subject><subject>Lymph Node Excision - methods</subject><subject>Lymph Nodes - pathology</subject><subject>Lymph Nodes - surgery</subject><subject>Lymphatic Metastasis - pathology</subject><subject>Middle Aged</subject><subject>Neoplasm Micrometastasis</subject><subject>Nomograms</subject><subject>Oncology</subject><subject>Pathology</subject><subject>Prospective Studies</subject><subject>Sentinel Lymph Node Biopsy - methods</subject><issn>1219-4956</issn><issn>1532-2807</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kc1u1DAUhS0EoqXwAGyQJTZsAr52nJ9lNTCANC1VoWwjx3GmLkkcfDOU7voQbHgJHqpP0ptOiyokJEu25O_cc3UOY89BvAYh8jcIUmqVCJBJqXNI1AO2C1rJRBYif0hvCWWSljrbYU8QzwRpsjJ7zHakErnQhd5lf47M5N0w4dXlb744Dd46Hga-_9N3nYkXfHXRj6f8MDSOv_WIzk6evpeh68K5H9b8M2n94Lr74IG3MfRuMkjHI7-6_MWXPuLEj90Y4jQbHMWA4zzth-MnSJ4tN6TuwzqanvuBf3Wzezjnxx6_8bstn7JHrenQPbu999jJ8t2XxYdk9en9x8X-KrEql1PSZFlb1I0qU2FNCQqghrQpRAqNcKIW1pnWFEDhpVIUQtnagFXQpGB1SaGpPfZqO3eM4fvG4VT1Hq2jTAYXNliBklkutc6A0Jf_oGdhEwfa7oZSKstyTRRsKYoGMbq2GqPvKeEKRDWXWW3LrKjMai6zUqR5cTt5U_eu-au4a48AuQWQvoa1i_es_zv1GlSwrKk</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Cserni, Gábor</creator><creator>Bezsenyi, Istvánné</creator><creator>Markó, László</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20130401</creationdate><title>Patients’ Choice on Axillary Lymph Node Dissection Following Sentinel Lymph Node Micrometastasis — First Report on Prospective Use of a Nomogram in Very Low Risk Patients</title><author>Cserni, Gábor ; Bezsenyi, Istvánné ; Markó, László</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-d66f8bd3940ca91311b14d8041d0e0b0ceafa81253420803cba1c31d41c592193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Axilla</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Cancer Research</topic><topic>Choice Behavior</topic><topic>Female</topic><topic>Humans</topic><topic>Immunology</topic><topic>Lymph Node Excision - methods</topic><topic>Lymph Nodes - pathology</topic><topic>Lymph Nodes - surgery</topic><topic>Lymphatic Metastasis - pathology</topic><topic>Middle Aged</topic><topic>Neoplasm Micrometastasis</topic><topic>Nomograms</topic><topic>Oncology</topic><topic>Pathology</topic><topic>Prospective Studies</topic><topic>Sentinel Lymph Node Biopsy - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cserni, Gábor</creatorcontrib><creatorcontrib>Bezsenyi, Istvánné</creatorcontrib><creatorcontrib>Markó, László</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest - Health & Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pathology oncology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cserni, Gábor</au><au>Bezsenyi, Istvánné</au><au>Markó, László</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patients’ Choice on Axillary Lymph Node Dissection Following Sentinel Lymph Node Micrometastasis — First Report on Prospective Use of a Nomogram in Very Low Risk Patients</atitle><jtitle>Pathology oncology research</jtitle><stitle>Pathol. Oncol. Res</stitle><addtitle>Pathol Oncol Res</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>19</volume><issue>2</issue><spage>211</spage><epage>216</epage><pages>211-216</pages><issn>1219-4956</issn><eissn>1532-2807</eissn><abstract>The optimal locoregional treatment of patients diagnosed with sentinel node (SN) micrometastasis is controversial. A previously reported and validated nomogram was used to calculate the risk of non-SN metastasis in patients with SN micrometastasis over a period of 2 years. Patients were given detailed information about the risk, consequences and treatment options of non-SN involvement, the risk and potential complications of unnecessary completion axillary lymph node dissection (ALND), the imperfectness of the nomogram, and other factors that may influence their selection of further treatment. They also received a questionnaire to monitor factors influencing their decisions. Of the 25 patients participating in the study, 10 have opted for ALND. The only factor that seemed to influence their choice was fear from disease recurrence. Giving detailed information to SN micrometastatic patients is a patient-centered alternative to current recommendations on performing ALND in all such patients or omitting ALND in all of them.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>23070585</pmid><doi>10.1007/s12253-012-9571-3</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1219-4956 |
| ispartof | Pathology oncology research, 2013-04, Vol.19 (2), p.211-216 |
| issn | 1219-4956 1532-2807 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1326725561 |
| source | MEDLINE; Springer journals |
| subjects | Adult Aged Axilla Biomedical and Life Sciences Biomedicine Breast Neoplasms - pathology Breast Neoplasms - surgery Cancer Research Choice Behavior Female Humans Immunology Lymph Node Excision - methods Lymph Nodes - pathology Lymph Nodes - surgery Lymphatic Metastasis - pathology Middle Aged Neoplasm Micrometastasis Nomograms Oncology Pathology Prospective Studies Sentinel Lymph Node Biopsy - methods |
| title | Patients’ Choice on Axillary Lymph Node Dissection Following Sentinel Lymph Node Micrometastasis — First Report on Prospective Use of a Nomogram in Very Low Risk Patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T17%3A42%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patients%E2%80%99%20Choice%20on%20Axillary%20Lymph%20Node%20Dissection%20Following%20Sentinel%20Lymph%20Node%20Micrometastasis%20%E2%80%94%20First%20Report%20on%20Prospective%20Use%20of%20a%20Nomogram%20in%20Very%20Low%20Risk%20Patients&rft.jtitle=Pathology%20oncology%20research&rft.au=Cserni,%20G%C3%A1bor&rft.date=2013-04-01&rft.volume=19&rft.issue=2&rft.spage=211&rft.epage=216&rft.pages=211-216&rft.issn=1219-4956&rft.eissn=1532-2807&rft_id=info:doi/10.1007/s12253-012-9571-3&rft_dat=%3Cproquest_cross%3E2943012421%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1326336675&rft_id=info:pmid/23070585&rfr_iscdi=true |